Literature DB >> 2689849

Equine laminitis--another hypothesis for pathogenesis.

J R Field1, L B Jeffcott.   

Abstract

Laminitis is an important condition in horses and ponies, not just because of the seriousness of the clinical signs and systemic changes involved, but because of the potentially poor prognosis and likelihood of recurrence. Laminitis is particularly prevalent in ponies and involves a multiplicity of aetiological factors. Fat ponies and those having previously suffered laminitis were found to be far more intolerant to oral glucose loading (1 g/kg bwt) than normal ponies or Standardbred horses. These ponies also exhibited a far greater response in plasma insulin levels after glucose loading. Insulin response tests (0.4 iu/kg bwt insulin intravenously) showed only a minimal and very protracted response in both the fat and laminitic ponies establishing the existence of an apparently innate insulin insensitivity in these animals. These findings are important in regulation of carbohydrate and lipid metabolism and play a role in the pathogenesis of laminitis. The reduction of insulin effectiveness leads to elevation in thromboxane A2 activity, predisposing the animal to peripheral vasoconstriction, compromisation of blood flow to the foot and the development of laminitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689849     DOI: 10.1016/0306-9877(89)90062-5

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

Review 1.  Medical implications of obesity in horses--lessons for human obesity.

Authors:  Philip J Johnson; Charles E Wiedmeyer; Nat T Messer; Venkataseshu K Ganjam
Journal:  J Diabetes Sci Technol       Date:  2009-01

2.  Weight loss is linearly associated with a reduction of the insulin response to an oral glucose test in Icelandic horses.

Authors:  Julien Delarocque; Florian Frers; Korinna Huber; Karsten Feige; Tobias Warnken
Journal:  BMC Vet Res       Date:  2020-05-24       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.